What impact will Alzheimer’s drug donanemab have?
by Ian Sample Science editor from Science | The Guardian on (#6D1NV)
While it is not a cure, proof that drugs can alter course of disease is regarded as significant triumph
A major clinical trial of an Alzheimer's drug has confirmed that the therapy can slow the rate at which patients deteriorate, raising hopes that medicine may one day halt the most common form of dementia. What impact could the new drug have?
Continue reading...